Sexual health issues in men with cancer

ONCOLOGY

Volumn 20, Issue 3, 2006, Pages 294-300

  Tal, Raanan ^a   Mulhall, John P ^b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b New York Presbyterian Hospital ^*  (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BCG VACCINE; CISPLATIN; HORMONE; PHOSPHODIESTERASE V INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TRICYCLIC ANTIDEPRESSANT AGENT;

BLADDER CANCER; BRACHYTHERAPY; CANCER PATIENT; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; ENDOCRINE DISEASE; ERECTILE DYSFUNCTION; FUNCTIONAL ASSESSMENT; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LIBIDO DISORDER; MALE; NEUROLOGIC DISEASE; ORGANIC IMPOTENCE; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PREVALENCE; PROSTATE CANCER; PROSTATECTOMY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL HEALTH; TESTIS CANCER;

EID: 34250613778     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55:10-30, 2005.
2. Incrocci L, Madalinska JB, Essink-Bot ML, et al: Sexual functioning in patients with localized prostate cancer awaiting treatment. J Sex Marital Ther 27:353-363, 2001.
3. Litwin MS, Lubeck DP, Henning JM, et al: Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: Results of the CaPSURE database. J Urol 159:1988-1992, 1998.
4. Ananth H, Jones L, King M, et al: The impact of cancer on sexual function: A controlled study. Palliat Med 17:202-205, 2003.
5. McKinlay JB, Digruttolo L, Glasser D, et al: International differences in the epidemiology of male erectile dysfunction. Int J Clin Pract Suppl 102:35, 1999.
6. Schover LR: Counseling cancer patients about changes in sexual function. Oncology (Williston Park, NY) 13:1585-1596 (incl discussion), 1999.
7. Costabile RA: Cancer and male sexual dysfunction. Oncology (Williston Park, NY) 14:195-205 (incl discussion), 2000.
8. Lidstone V, Butters E, Seed PT, et al: Symptoms and concerns amongst cancer outpatients: Identifying the need for specialist palliative care. Palliat Med 17:588-595, 2003.
9. Rajagopal A, Vassilopoulou-Sellin R, Palmer JL, et al: Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 100:851-858, 2004.
10. Daniell HW: Hypogonadism in men consuming sustained-action oral opioids. J Pain 3:377-384, 2002.
11. Clayton DO, Shen WW: Psychotropic drug-induced sexual function disorders: Diagnosis, incidence and management. Drug Saf 19:299-312, 1998.
12. Koeman M, van Driel MF, Schultz WC, et al: Orgasm after radical prostatectomy. Br J Urol 77:861-864, 1996.
13. Barnas JL, Pierpaoli S, Ladd P, et al: The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int 94:603-605, 2004.
14. Chen CT, Valicenti RK, Lu J, et al: Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer? Int J Radiat Oncol Biol Phys 50:591-595, 2001.
15. Munding MD, Wessells HB, Dalkin BL: Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 58:567-569, 2001.
16. Savoie M, Kim SS, Soloway MS: A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 169:1462-1464, 2003.
17. Higano CS: Side effects of androgen deprivation therapy: Monitoring and minimizing toxicity. Urology 61:32-38, 2003.
18. Hollenbeck BK, Wei JT, Sanda MG, et al: Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer. Urology 63:946-950, 2004.
19. Che M, Tamboli P, Ro JY, et al: Bilateral testicular germ cell tumors: Twenty-year experience at M. D. Anderson Cancer Center. Cancer 95:1228-1233, 2002.
20. Nord C, Bjoro T, Ellingsen D, et al: Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 44:322-328, 2003.
21. Chatterjee R, Kottaridis PD, McGarrigle HH, et al: Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant 29:607-610, 2002.
22. Mertens AC, Ramsay NK, Kouris S, et al: Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant 22:345-350, 1998.
23. Pai HH, Thornton A, Katznelson L, et al: Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: Demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 49:1079-1092, 2001.
24. Baker HW: Reproductive effects of nontesticular illness. Endocrinol Metab Clin North Am 27:831-850, 1998.
25. Banerjee AK: Sexual dysfunction after surgery for rectal cancer. Lancet 353:1900-1902, 1999.
26. Mirone V, Imbimbo C, Palmieri A, et al: Erectile dysfunction after surgical treatment. Int J Androl 26:137-140, 2003.
27. Basavaraju SR, Easterly CE: Pathophysiological effects of radiation on atherosclerosis development and progression, and the incidence of cardiovascular complications. Med Phys 29:2391-2403, 2002.
28. Incrocci L, Slob AK, Levendag PC: Sexual (dys)function after radiotherapy for prostate cancer: A review. Int J Radiat Oncol Biol Phys 52:681-693, 2002.
29. De Luca V, Pescatori ES, Taher B, et al: Damage to the erectile function following radical pelvic surgery: Prevalence of veno-occlusive dysfunction. Eur Urol 29:36-40, 1996.
30. Montorsi F, Briganti A, Salonia A, et al: Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol 45:123-133, 2004.
31. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov), DevCan database: SEER Incidence and Mortality, 1993-2001. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004.
32. Wei JT, Dunn RL, Sandler HM, et al: Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol 20:557-566, 2002.
33. Stanford JL, Feng Z, Hamilton AS, et al: Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 283:354-360, 2000.
34. Merrick GS, Wallner KE, Butler WM: Management of sexual dysfunction after prostate brachytherapy. Oncology (Williston Park, NY) 17:52-73 (incl discussion), 2003.
35. Clark JA, Inui TS, Silliman RA, et al: Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 21:3777-3784, 2003.
36. Brucker PS, Cella D: Measuring self-reported sexual function in men with prostate cancer. Urology 62:596-606, 2003.
37. Litwin MS, Flanders SC, Pasta DJ, et al: Sexual function and bother after radical prostatectomy or radiation for prostate cancer: Multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 54:503-508, 1999.
38. Talcott JA, Manola J, Clark JA, et al: Time course and predictors of symptoms after primary prostate cancer therapy. J Clin Oncol 21:3979-3986, 2003.
39. Potosky AL, Davis WW, Hoffman RM, et al: Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst 96:1358-1367, 2004.
40. Penson DF, Feng Z, Kuniyuki A, et al: General quality of life 2 years following treatment for prostate cancer: What influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 21:1147-1154, 2003.
41. Rabbani F, Stapleton AM, Kattan MW, et al: Factors predicting recovery of erections after radical prostatectomy. J Urol 164:1929-1934, 2000.
42. Robinson JW, Moritz S, Fung T: Metaanalysis of rates of erectile function after treatment of localized prostate carcinoma. Int J Radiat Oncol Biol Phys 54:1063-1068, 2002.
43. Walsh PC: Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate. J Urol 163:1802-1807, 2000.
44. Kundu SD, Roehl KA, Eggener SE, et al: Potency, continence and complications in 3,477 consecutive radical retropubic prostatectomies. J Urol 172:2227-2231, 2004.
45. Rassweiler J, Schulze M, Teber D, et al: Laparoscopic radical prostatectomy: Functional and oncological outcomes. Curr Opin Urol 14:75-82, 2004.
46. Lowentritt BH, Scardino PT, Miles BJ, et al: Sildenafil citrate after radical retropubic prostatectomy. J Urol 162:1614-1617, 1999.
47. Zelefsky MJ, McKee AB, Lee H, et al: Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 53:775-778, 1999.
48. Merrick GS, Butler WM, Lief JH, et al: Efficacy of sildenafil citrate in prostate brachytherapy patients with erectile dysfunction. Urology 53:1112-1116, 1999.
49. Schoenberg MP, Walsh PC, Breazeale DR, et al: Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 155:490-494, 1996.
50. Brendler CB, Steinberg GD, Marshall FF, et al: Local recurrence and survival following nerve-sparing radical cystoprostatectomy. J Urol 144:1137-1141 (incl discussion), 1990.
51. Ries LAG, Eisner MP, Kosary CL et al: SEER Cancer Statistics Review, 1975-2001. Bethesda, Md; National Cancer Institute; 2004.
52. Jonker-Pool G, Van de Wiel HB, Hoekstra HJ, et al: Sexual functioning after treatment for testicular cancer - review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav 30:55-74, 2001.
53. Baniel J, Foster RS, Rowland RG, et al: Complications of primary retroperitoneal lymph node dissection. J Urol 152:424-427, 1994.
54. Heidenreich A, Albers P, Hartmann M, et al: Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169:1710-1714, 2003.
55. Jacobsen KD, Ous S, Waehre H, et al: Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection. Br J Cancer 80:249-255, 1999.
56. Windahl T, Andersson SO: Combined laser treatment for penile carcinoma: Results after long-term followup. J Urol 169:2118-2121, 2003.
57. Pietrzak P, Corbishley C, Watkin N: Organ-sparing surgery for invasive penile cancer: Early follow-up data. BJU Int 94:1253-1257, 2004.
58. D'Ancona CA, Botega NJ, De Moraes C, et al: Quality of life after partial penectomy for penile carcinoma. Urology 50:593-596, 1997.
59. Windahl T, Skeppner E, Andersson SO, et al: Sexual function and satisfaction in men after laser treatment for penile carcinoma. J Urol 172:648-651, 2004.